← Leaderboards
John P O'Bryan
Medical University Of South Carolina
$5,496,943
Attributed
$8,764,571
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,764,571 · 6
VA$0 · 1
By mechanism
R01$6,963,917 · 3
T32$1,298,771 · 1
R21$491,883 · 1
R13$10,000 · 1
I01$0 · 1
Top collaborators
- Shohei Koide11 shared
- Amy Dodd Bradshaw2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSignal TransductionIn VivoBinding ProteinsMalignant NeoplasmsMediatingFamilyTumorigenesisProteinsBiologyOncogenicInsightMalignant Neoplasm Of PancreasMolecularMutationAffinitySpecificityTechnologyProtein IsoformsTumorMutateMutantNovel StrategiesPrevent
Grant awards (44)
Cellular, Biochemical and Molecular Sciences Training Program$639,540
T32 · FY2025 · GM · contact PI
Probing RAS-mediated Signaling with Monobody Inhibitors$588,746
R01 · FY2025 · CA · contact PI
Cellular, Biochemical and Molecular Sciences Training Program$659,231
T32 · FY2024 · GM · contact PI
Probing RAS-mediated Signaling with Monobody Inhibitors$559,309
R01 · FY2024 · CA · contact PI
The Regulation and Function of Small GTPases$10,000
R13 · FY2024 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2024 · VA · contact PI
Probing RAS-mediated Signaling with Monobody Inhibitors$576,970
R01 · FY2023 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2023 · VA · contact PI
Probing RAS-mediated Signaling with Monobody Inhibitors$601,496
R01 · FY2022 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2022 · VA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$551,022
R01 · FY2021 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2021 · VA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$551,022
R01 · FY2020 · CA · contact PI
Probing Ras-mediated signaling mechanisms with monobody inhibitors$152,515
R01 · FY2020 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2020 · VA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$534,490
R01 · FY2019 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2019 · VA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$543,570
R01 · FY2018 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2018 · VA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$397,436
R01 · FY2017 · CA · contact PI
Probing RAS-mediated signaling mechanisms with monobody inhibitors$179,910
R01 · FY2017 · CA · contact PI
Development of novel RAS inhibitory agents for cancer therapy$173,230
R21 · FY2017 · CA · contact PI
Development of novel RAS inhibitory agents for cancer therapy$66,319
R21 · FY2017 · CA · contact PI
Novel Functions for Ras family GTPases$0
I01 · FY2017 · VA · contact PI
Development of novel RAS inhibitory agents for cancer therapy$220,888
R21 · FY2016 · CA · contact PI
Development of novel Ras inhibitory agents for cancer therapy"$31,446
R21 · FY2016 · CA · contact PI
Novel Functions for Ras Family GTPases$0
I01 · FY2016 · VA · contact PI
Novel Functions for Ras Family GTPases$0
I01 · FY2015 · VA · contact PI
Cath B and uPAR si RNA constructs regressed glioma growth$320,546
R01 · FY2014 · CA · contact PI
Novel Functions for Ras Family GTPases$0
I01 · FY2014 · VA · contact PI
Cath B and uPAR si RNA constructs regressed glioma growth$310,632
R01 · FY2013 · CA · contact PI
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction$272,003
R01 · FY2012 · HL · contact PI
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction$274,750
R01 · FY2011 · HL · contact PI
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction$274,750
R01 · FY2010 · HL · contact PI
Regulation Of Ischemic Preconditioning By Compartmentalized Signal Transduction$274,750
R01 · FY2009 · HL · contact PI
Role Of Intersectin Adaptor Protein In Regulation Of End$0
Z01 · FY2005 · ES
Intersectin Adaptor Protein In Regulation Of Endocytosis$0
Z01 · FY2004 · ES
Role Of Intersectin Adaptor Protein In Regulation Of End$0
Z01 · FY2003 · ES
Role Of Intersectin Adaptor Protein In Regulation Of End$0
Z01 · FY2002 · ES
Shcc Function In Growth, Development And Cancer$0
Z01 · FY2002 · ES
Role Of Intersectin Adaptor Protein In Regulation Of End$0
Z01 · FY2001 · ES
Shcc Function In Growth, Development And Cancer$0
Z01 · FY2001 · ES
Role of Intersectin Adaptor Protein in Regulation of Endocytosis and Signaling$0
Z01 · FY2000 · ES
ShcC Function in Growth, Development and Cancer$0
Z01 · FY2000 · ES